
Currently out of the existing stock ratings of Oliver Reinberg, 1 are a SELL (20%), 2 are a HOLD (40%), 2 are a BUY (40%).
Analyst Oliver Reinberg, currently employed at KEPLER CHEUVREUX, has had 16.67% of price targets met with an average potential upside of 9.85%, reached in 120 days on average.
Oliver Reinberg has documented 10 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on QGEN, Qiagen NV at 13-Jul-2021.
Analyst best performing recommendations are on QGEN (QIAGEN NV).
The best stock recommendation documented was for QGEN (QIAGEN NV) on 11/14/2019. The price target of $40.53 was fulfilled within 239 days with a profit of $6.67 (19.7%), with a performance score of 0.82.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 07-Jan-2020
$50
$-0.1 (-0.20%)
$52
4 days ago
(12-Nov-2026)
Buy Since 27-Oct-2026
$53
$2.9 (5.79%)
$55
20 days ago
(27-Oct-2026)
3/9 (33.33%)
$2.83 (5.64%)
154
Buy Since 17-Jun-2024
$52
$1.9 (3.79%)
$55
26 days ago
(21-Oct-2026)
2/6 (33.33%)
$1.78 (3.54%)
114
Buy Since 21-Oct-2026
$52
$1.9 (3.79%)
$43
26 days ago
(21-Oct-2026)
5/9 (55.56%)
$1.78 (3.54%)
253
Hold Since 05-Oct-2026
$55
$4.9 (9.78%)
$35.72
1 months 11 days ago
(05-Oct-2026)
5/6 (83.33%)
$9.35 (20.48%)
534
What Year was the first public recommendation made by Oliver Reinberg?